Mabpharm Limited（02181.HK）股价、图表、新闻与AI分析

Q: MABPHARM-B 股票的价格表现如何？

MABPHARM-B 的当前价格为 $0.51，在上个交易日 上升 了 2%。

Q: Mabpharm Limited 的主要业务主题或行业是什么？

Mabpharm Limited 属于 Biotechnology 行业，该板块是 Health Care

Q: Mabpharm Limited 的市值是多少？

Mabpharm Limited 的当前市值是 $2.1B

主页

股票

02181.HK

MABPHARM-B (02181.HK)

Mabpharm Limited

HK$0.51

2%

$0.01

休市： Jan 16, 16:00:00 HKT

关键数据

前收盘价

$0.52

开盘价

$0.5

当日区间

$0.5 - $0.51

52周范围

$0.25 - $0.94

交易量

12.0K

平均成交量

88.2K

每股收益（TTM）

-0.01

股息收益率

市值

$2.1B

什么是 MABPHARM-B？

Mabpharm Ltd. engages in the research, development, and manufacture of monoclonal antibody drugs for the treatment of cancer and autoimmune diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 383 full-time employees. The company went IPO on 2019-05-31. The Company’s main products include CMAB009 Enlituo (cetuximab β injection), CMAB007 Aomaishu (Omalizumab α for Injection), CMAB008 Leiting (infliximab for injection) and other products. The Company’s products are mainly used for colorectal cancer, asthma, urticaria, rheumatoid arthritis, ulcerative colitis in adults and other diseases. The firm is also engaged in the transfer of intellectual property. The firm mainly conducts its business in the domestic market.

功能特性

交易策略